Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT00098280 · COMPLETED

Trial details

NCT number: NCT00098280
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemoglobinuria, Paroxysmal

Start date: 2004-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.